Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why Grail Stock Slumped Again Today


Grail (NASDAQ: GRAL) stock came under even more pressure today, declining by more than 16% by 12:40 a.m. The move comes as the market continues to digest the unpalatable news that hit the market on Friday. The news wasn't good, but there is a pathway to recovery, however tenuous it might appear now.

I discussed the game-changing event on Friday. Simply put, the company's trial of its Galleri multi-cancer early detection (MCED) with England's National Health Service (NHS) failed to meet its primary endpoint of demonstrating a "statistically significant Stage III-IV reduction" in cancer detection rates.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments